Whales with a lot of money to spend have taken a noticeably bullish stance on Insulet.
Looking at options history for Insulet PODD we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $337,712 and 2, calls, for a total amount of $96,390.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $190.0 to $200.0 for Insulet over the last 3 months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Insulet's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Insulet's whale trades within a strike price range from $190.0 to $200.0 in the last 30 days.
Insulet Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| PODD | PUT | SWEEP | BEARISH | 03/15/24 | $195.00 | $63.2K | 469 | 71 |
| PODD | PUT | SWEEP | BULLISH | 06/21/24 | $200.00 | $59.4K | 5 | 137 |
| PODD | PUT | SWEEP | BULLISH | 06/21/24 | $200.00 | $57.7K | 5 | 110 |
| PODD | CALL | SWEEP | BEARISH | 06/21/24 | $195.00 | $56.8K | 52 | 11 |
| PODD | PUT | SWEEP | NEUTRAL | 03/15/24 | $190.00 | $44.2K | 666 | 56 |
About Insulet
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
In light of the recent options history for Insulet, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Insulet
- Trading volume stands at 250,672, with PODD's price down by 0.0%, positioned at $198.75.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 14 days.
What The Experts Say On Insulet
In the last month, 1 experts released ratings on this stock with an average target price of $208.0.
- An analyst from Stifel persists with their Hold rating on Insulet, maintaining a target price of $208.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Insulet, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
